Absorbing the Cost of Personalized Medicine

Matthew C. Palmgren, PharmD

Video Categories: Pricing

Matthew Palmgren discusses the benefits of personalized medicines

October 16, 2015

Pembrolizumab vs. Ipilimumab

Dr. Sanjiv Agarwala discusses the pros and cons of using Pembrolizumab over anti-CTLA4 antibody therapy.

December 12, 2016

New Effective Targets

Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.